Dose study of vinpocetine in healthy volunteers
Treatments studied
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial tests increasing doses of vinpocetine, a supplement used for brain health, in healthy adults. The goal is to see how safe and tolerable different doses are.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You are in good general health, with no major medical conditions like epilepsy, diabetes, heart disease, active cancer, or depression.
- You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
- You have not taken any medications that affect the central nervous system recently.
- You have no history of allergy to vinpocetine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a choline supplement during pregnancy can reduce harmful effects on the baby when a person drinks heavily while pregnant. It may help support healthier pregnancy and baby outcomes for those who meet the study’s drinking and nutrition criteria.
This study tests whether brain stimulation plus structured thinking practice can improve thinking and brain function in people affected by heavy alcohol exposure before birth. It may help parents and researchers learn how to support learning and daily functioning in fetal alcohol spectrum disorders.
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with alcohol use disorder. The goal is to better understand how alcohol affects the brain, which may lead to new treatments.
This trial studies whether taking an NAD supplement can support brain blood vessel health as people age. Participants will be tested for brain and health changes and may help researchers understand how to keep the brain’s blood vessels healthier over time.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This study looks at unborn babies exposed to alcohol during pregnancy and compares them with babies not exposed. Researchers test a pregnancy blood marker to see whether it may relate to early brain changes in the baby.
Hear when a new Fetal Alcohol Spectrum Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.